The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Osteoporosis After Orchiectomy for Prostate Cancer
Abstract
No AccessJournal of UrologyClinical Urology: Original Article1 Feb 1997Osteoporosis After Orchiectomy for Prostate Cancer Harry W. Daniell Harry W. DaniellHarry W. Daniell More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(01)65165-6AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract Purpose: The possibility of increased osteoporosis and osteoporotic fractures following therapeutic orchiectomy in men with prostate cancer was investigated. Materials and Methods: A total of 235 men with nonstage A prostate cancer diagnosed between 1983 and 1990 was analyzed for therapeutic orchiectomy, other osteoporotic risk factors and subsequent hospital treatment for osteoporotic fractures. The 17 castrated men alive in 1995 were interviewed, and femoral neck bone mineral density was compared to that of 23 controls of similar age. Results: Risk factors for osteoporosis, including smoking, slender habitus and atrophic testes, were common among men treated with orchiectomy. Of the men in the study cohort 10 had osteoporotic fractures: 8 of 59 treated with and 2 of 176 without orchiectomy (13.6 versus 1.1%, p <0.001). First fracture cumulative incidence rates 7 years after castration or diagnosis were 28 and 1%, respectively (p <0.001). Osteoporotic fractures were much more common than pathological fractures or those due to major trauma (1 each). Bone mineral density averaged 0.91, 0.84, 0.79 and 0.66 gm./cm.2 in 9 controls without prostate cancer, 14 men with prostate cancer before orchiectomy, 9 men at 9 to 60 and 8 men at 60 to 115 months after orchiectomy, respectively. Of the 16 men surviving for longer than 60 months after orchiectomy 6 had osteoporotic fractures, as did 5 of 6 and 5 of 7 with a bone mineral density of less than 0.70 gm./cm.2 and less than 75% of normal for age, respectively. Conclusions: Orchiectomy for prostate cancer is frequently followed by severe osteoporosis, some of which had developed before castration. Appropriate therapy should be identified that does not diminish the antitumorigenic effectiveness of androgen ablation. References 1 : Severe osteoporosis in men. Ann. Intern. Med.1995; 123: 452. Google Scholar 2 : Risk factors for spinal osteoporosis in men. Amer. J. Med.1983; 75: 977. Google Scholar 3 : Pathogenesis of vertebral crush fractures in men. Age Aging1992; 21: 139. Google Scholar 4 : Does hypogonadism contribute to the occurrence of a minimal trauma hip fracture in elderly men?. J. Amer. Geriatr. Soc.1991; 39: 766. Google Scholar 5 : Testosterone deficiency as a risk factor for hip fractures in men: a case-control study. Amer. J. Med. Sci.1992; 304: 4. Google Scholar 6 : Carcinoma of the prostate. In: Adult and Pediatric Urology. Edited by . St. Louis: The C. V. Mosby Co.1991: 1277. part 1, chapt. 34. Google Scholar 7 : Adenocarcinoma of the prostate. In: Campbell's Urology. Edited by . Philadelphia: W. B. Saunders Co.1992: 1159. chapt. 29. Google Scholar 8 : Prostate cancer. In: Cancer, Principals and Practices of Oncology. Edited by . Philadelphia: J. B. Lippincott Co.1993: 1073. Google Scholar 9 : Management of hormonal treatment effects. Cancer1995; 75: 1983. Google Scholar 10 : Hormonal therapy in the treatment of carcinoma of the prostate. Cancer1995; 75: 1914. Google Scholar 11 : A worse prognosis for smokers with prostate cancer. J. Urol.1995; 154: 153. Link, Google Scholar 12 : A better prognosis for obese men with prostate cancer. J. Urol.1996; 155: 220. Link, Google Scholar 13 Daniell, H. W. and Tam, E. W.: Increased testicular atrophy following prostate bed radiation therapy for prostate cancer. Unpublished data. Google Scholar 14 : Osteoporosis of the slender smoker. Vertical compression fractures and loss of metacarpal cortex in relation to postmenopausal cigarette smoking and lack of obesity. Arch. Intern. Med.1976; 136: 298. Google Scholar 15 : Prognostic factors of advanced prostatic carcinoma. Ann. Chir. Gynaec.1993; 206: 9. Google Scholar 16 : Prognostic factors in survival free of progression after androgen deprivation therapy for treatment of prostate cancer. J. Urol.1989; 141: 1139. Link, Google Scholar 17 : Pre-treatment testosterone levels: significance in androgen deprivation therapy. J. Urol.1986; 136: 1038. Link, Google Scholar 18 : Independent prognostic factors in patients with metastatic (stage D2) prostate cancer. The Zoladex Study Group. J.A.M.A.1991; 265: 618. Google Scholar 19 : Analysis of prognostic factors in men with metastatic prostate cancer. J. Urol.1991; 146: 372. Abstract, Google Scholar 20 : Prognostic value of serum hormone concentrations in prostatic cancer. Prostate1988; 13: 249. Google Scholar 21 : Plasma testosterone levels in patients with prostatic carcinoma before and after treatment. J. Urol.1968; 99: 788. Link, Google Scholar 22 : Castrated men exhibit bone loss: effect of calcitonin treatment on biochemica
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Risk factors for spinal osteoporosis in men
Seeman, E., Melton, L. J., O'Fallon, W. M., & Riggs, B. L. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)90878-1 · Cited by 659
ŠTĚPÁN, J. J., LACHMAN, M., ZVĚŘINA, J., PACOVSKÝ, V., & BAYLINK, D. J. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-69-3-523 · Cited by 424
Osteoporosis in Men with Idiopathic Hypogonadotropic Hypogonadism
FINKELSTEIN, J. S., KLIBANSKI, A., NEER, R. M., GREENSPAN, S. L., ROSENTHAL, D. I., & CROWLEY, W. F. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-3- · Cited by 408
Daniell (1976) · doi:10.1001/archinte.1976.03630030032007 · Cited by 301
Does Hypogonadism Contribute to the Occurrence of a Minimal Trauma Hip Fracture in Elderly Men?
Stanley, H. L., Schmitt, B. P., Poses, R. M., & Deiss, W. P. (1991) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1991.tb02698.x · Cited by 264
Kelepouris, N., Harper, K. D., Gannon, F., Kaplan, F. S., & Haddad, J. G. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-6-199509150-00010 · Cited by 201
The Effect of a Gonadotropin-Releasing Hormone Agonist Analog (Nafarelin) on Bone Metabolism
JOHANSEN, J. S., RIIS, B. J., HASSAGER, C., MOEN, M., JACOBSON, J., & CHRISTIANSEN, C. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-4-701 · Cited by 189
Testosterone Deficiency As a Risk Factor for Hip Fractures in Men: A Case-Control Study
Jackson, J. A., Riggs, M. W., & Spiekerman, A. M. (1992) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199207000-00003 · Cited by 183
Goldray, D. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.76.2.288 · Cited by 174
Pathogenesis of Vertebral Crush Fractures in Men
BAILLIE, S. P., DAVISON, C. E., JOHNSON, F. J., & Francis, R. M. (1992) · Age and Ageing · doi:10.1093/ageing/21.2.139 · Cited by 139
Cited by
Saad, F., Gleason, D. M., Murray, R., Tchekmedyian, S., Venner, P., Lacombe, L., Chin, J. L., Vinholes, J. J., Goas, J. A., & Chen, B. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.19.1458 · Cited by 1,656
Kirby, M., Hirst, C., & Crawford, E. D. (2011) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2011.02799.x · Cited by 861
Vanderschueren, D., Vandenput, L., Boonen, S., Lindberg, M. K., Bouillon, R., & Ohlsson, C. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0003 · Cited by 717
Pamidronate to Prevent Bone Loss during Androgen-Deprivation Therapy for Prostate Cancer
Smith, M. R., McGovern, F. J., Zietman, A. L., Fallon, M. A., Hayden, D. L., Schoenfeld, D. A., Kantoff, P. W., & Finkelstein, J. S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010845 · Cited by 696
Osteoporosis in Men: An Endocrine Society Clinical Practice Guideline
Watts, N. B., Adler, R. A., Bilezikian, J. P., Drake, M. T., Eastell, R., Orwoll, E. S., & Finkelstein, J. S. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3045 · Cited by 611
Metadata
- Authors
- Daniell, H. W.
- Venue
- Journal of Urology
- Published
- 1997-02
- Volume
- 157
- Issue
- 2
- Pages
- 439-444
- ISSN
- 0022-5347 (ISSN-L)
- 1527-3792
- OpenAlex
- W4240322662
- Cited by
- 315
- References
- 22
- FWCI
- 10.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Osteoporosis After Orchiectomy for Prostate Cancer. https://app.cochat.ai/papers/10.1016/s0022-5347(01)65165-6
- The paper
- Daniell, H. W. (1997). Osteoporosis After Orchiectomy for Prostate Cancer. Journal of Urology. https://doi.org/10.1016/s0022-5347(01)65165-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.